Pay in 4 interest-free payments of $46.03 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
CXCL9 has been identified as a potential biomarker and therapeutic target
is a protein encoded by the TNFSF12 gene in humans
The effect of interferon response status and is strictly regulated
The TNF-α in the samples was bound to the solid phase antibody and detection antibody
including lissencephaly and double cortex syndrome
Human VAChT ELISA Kit Others CXCL9 has been identified asProduct Specification Usage Required experimental equipment: 1. Microplate reader (450nm) 2. High precision pipettes and pipette tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37C incubator 4. Distilled or deionized water Sample preparation and requirements: Tissue homogenization: Rinse the tissue with pre chilled PBS (0. 01M, pH 7. 4) to remove residual blood (lysed red blood cells in the homogenate will affect the measurement results). Weigh and
US$ 18787.50
US$ 10.50
US$ 71.40
US$ 25.20
US$ 137.55
US$ 60.00
US$ 278.00
US$ 42.00